Transforming the treatment landscape to treat fibrotic diseases

Cincera Therapeutics is a privately held biotechnology company based in Adelaide and Melbourne, Australia. The company is focused on the discovery and development of new drugs aiming to treat inflammatory and fibrotic conditions associated with metabolic diseases. This will have many potential applications in other disease areas including cancer.

We discover and drug novel targets once thought beyond reach, unlocking transformative therapies for fibrotic diseases.